Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Nov 21, 2017; 23(43): 7727-7734
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7727
Table 2 Dose changes at different time points after thalidomide treatment
Patient No.Dose (mg/kg per day) at different follow-up time (mo)
12.5 (baseline) - 2.5 (1 mo) - 1.2 (12 mo) - discontinue (34 mo)
22.5 (baseline) - discontinue (7 mo)
32 (baseline) - 1.1 (12 mo) - 0.7(18 mo) - 0.4 (21 mo) - 0.33 (33 mo)
41.8 (baseline) - 3 (5 mo) - 1 (12 mo) - 0.8 (15 mo)
52 (baseline) - 0.5 (2 mo) - 1.8(9 mo) - discontinue (22 mo) - 0.5 (36 mo)
61.2 (baseline) - 0.6 (12 mo)
72 (baseline) - 1.8 (1 mo) - 1.1 (10 mo) – stop (44 mo)
82 (baseline) – 2.4 (10 mo) - 1.6 (16 mo)
92.2 (baseline) -1.4 (5 mo) - 1.8 (9 mo)
101.8 (baseline) -1.3 (9 mo)